{"name":"Tianshu Liu","slug":"tianshu-liu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-02","type":"trial","source":"Finansavisen","summary":"Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 20","headline":"Jazz Pharmaceuticals to Present Pivotal Phase 3 Results of Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2-P","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}